The FDA has approved GlaxoSmithKline's shingles vaccine Shingrix for use in people aged under 50 who are immunocompromised – a key step in the UK drugmaker's plan to build the shot into a £4 ...
2 SHINGRIX is approved for the prevention of shingles (herpes zoster) in adults aged 50 years and older. AREXVY is approved for the prevention of lower respiratory tract disease (LRTD) caused by ...
Patients are urged to speak to their GP to check if they are eligible. The Shingrix vaccine can be administered in a pharmacy or a GP but given the expanded criteria, it requires a discussion ...